Publication of Information Memorandum regarding Kopy

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Publication of Information Memorandum regarding Kopy Goldfields' forthcoming capital raising

PUBLICATION OF INFORMATION MEMORANDUM REGARDING KOPY GOLDFIELDS FORTHCOMING CAPITAL RAISING Kopy Goldfields AB (publ) ("Kopy Goldfields" or "the Company") has today published an information memorandum regarding the issue of new shares with preferential rights for the Companys existing shareholders with a subscription period that starts on 26 September 2016. This press release may not be released, published or distributed, directly or indirectly, in or into the United States, Australia, Canada, South Africa, Hong Kong, Japan or New Zealand or any other jurisdiction where such action is wholly or partially subject to legal restrictions. The information in this press release does not constitute an offer to acquire, subscribe for or otherwise trade in shares, subscription rights or other securities in Kopy Goldfields AB (publ). For further information, please refer to "Important Information" in this press release. The Board of Kopy Goldfields has prepared an Information Memorandum in connection with the rights issue of MSEK 20.0 with preferential rights for existing shareholders of Kopy Goldfields. The rights issue in summary The holders of shares in Kopy Goldfields on the record date 21 September 2016 have preferential rights. Three (3) existing shares held on the record date entitle the holder to subscribe for one (1) new share in the rights issue. The issue price is SEK 1.00 per share. Subscription of shares with preferential rights shall be made by cash payment during the period from and including 26 September up to and including 10 October 2016. Subscription for shares without preferential rights shall be made through a subscription application during the same period. Trading in subscription rights will take place from and including 26 September up to and including 6 October 2016. Trading in paid subscription rights (BTA) will take place from and including 26 October until the Swedish Companies Registration Office (sv. Bolagsverket) has registered the issue. All terms and conditions can be read in the Information Memorandum, which is available in English at: www.aqurat.se http://www.aqurat.se and on the Companys homepage www.kopygoldfields.com http://www.kopygoldfields.com . Financial advisor and Issuing Agent Stockholm Corporate Finance is acting as financial advisor in the Rights Issue. Aqurat Fondkommission AB is acting as Issuing Agent in the Rights Issue. This is a translation of the Swedish version. In case of any discrepancy between the English and the Swedish version, the Swedish version shall take precedence. Stockholm, 23 September 2016 For further information, please contact Mikhail Damrin, VD, +7 916 808 12 17, mikhail.damrin@kopygoldfields.com mailto:mikhail.damrin@kopygoldfields.com Tim Carlsson, CFO, + 46 702 31 87 01, tim.carlsson@kopygoldfields.com mailto:tim.carlsson@kopygoldfields.com The following documents can be retrieved from beQuoted Kopy Goldfields 2016-09-23 English.pdf - http://www.bequoted.com/beQPress/download.asp?Id=18732 Kopy Goldfields 2016-09-23 Svenska.pdf - http://www.bequoted.com/beQPress/download.asp?Id=18733 This information is information that Kopy Goldfields AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 8.45 am CEST on September 23, 2016. About Kopy Goldfields AB Kopy Goldfields AB (publ), listed at NASDAQ First North in Stockholm is a gold exploration and production company operating in one of the most gold rich areas in the world; Lena Goldfields, Bodaibo, Russia. The company holds 11 bedrock exploration- and production licenses and one alluvial license covering in total 1,963 sq km, of which the Krasny licenses (bedrock and alluvial) are held 49% by the company. The target for Kopy Goldfields is to become a near-term gold producer in cooperation with a producing partner under JV agreement. Kopy Goldfields AB applies International Financial Reporting Standards (IFRS), as approved by the European Union. Aqurat Fondkommission acts as Certified Adviser, contact number: +46-8-684 05 800. The Share Ticker: KOPY http://www.nasdaqomxnordic.com/shares/microsi...t=SSE77457 http://www.nasdaqomxnordic.com/shares/microsi...t=SSE77457 Outstanding shares: 59,899,541 IMPORTANT INFORMATION The information in this press release does not constitute an offer to acquire, subscribe for or otherwise trade in shares, subscription rights or other securities in Kopy Goldfields AB (publ). This press release may not be released, published or distributed, directly or indirectly, in or into the United States, Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or any other jurisdiction where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, registrations or other actions in addition to what follows from Swedish law. Nor may the information in this press release be forwarded, reproduced or disclosed in a manner that contravenes such restrictions or would entail such requirements. Failure to comply with this instruction may result in a violation of applicable securities laws. No subscription rights, BTAs (interim shares) or shares have or will be registered under the U.S. Securities Act of 1933, as amended, or securities legislation in any state or other jurisdiction in the United States and may not be offered or sold, directly or indirectly, in or into the United States.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 16

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 9

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 12

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 15

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 5

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 15

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 7

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 12

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 12

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 15

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading

Top 5 Most Recently Viewed Articles

Ikena Oncology and Inmagene Form Strategic Merger to Advance Cancer Therapies

Updated Category News Views 137

Overview of the Merger and Collaboration Ikena Oncology, Inc. and Inmagene Biopharmaceuticals have announced an exciting merger agreement that aims to amplify their efforts in developing innovative treatment options for patients suffering from inflammatory diseases. The merger is designed to streamline the development of IMG-007, a cutting-edge therapeutic candidate...

Continue Reading
Tempest’s Amezalpat Therapy Receives Crucial Approval in China

Updated Category News Views 209

Tempest Therapeutics Advances Amezalpat in Pivotal Trial Tempest Therapeutics, Inc. (Nasdaq: TPST) is thrilled to announce a major step forward in the fight against hepatocellular carcinoma (HCC), having received approval from China’s National Medical Products Administration (NMPA) to initiate a pivotal trial. This trial aims to evaluate the efficacy of amezalpat...

Continue Reading
Chicago Atlantic BDC, Inc. Announces Impressive Dividend Payout

Updated Category News Views 96

Chicago Atlantic BDC, Inc. Announces Dividend for the Upcoming Quarter In a notable development, Chicago Atlantic BDC, Inc. has declared a cash dividend of $0.34 per share for the upcoming quarter. This announcement is a significant milestone for shareholders, reflecting the company's solid financial foundation and commitment to returning value to its investors. This...

Continue Reading
Be Bio Secures $92 Million to Propel Clinical Innovations

Updated Category News Views 186

Be Bio Secures $92 Million to Propel Clinical Innovations Be Biopharma, Inc. (NASDAQ: BIO), a front-runner in B Cell Medicines, has successfully closed a significant $92 million Series C financing round. This milestone will undoubtedly bolster their mission of advancing innovative therapies. The financing has drawn interest from a mix of new and existing investors,...

Continue Reading
Lifecore Biomedical's Q2 2025 Financial Results Announcement

Updated Category News Views 226

Lifecore Biomedical to Report Second Quarter Financial Results Lifecore Biomedical, Inc. (NASDAQ: LFCR), a prominent contract development and manufacturing organization (CDMO), is gearing up to share its financial outcomes for the second quarter of fiscal year 2025. The report is scheduled for January 2, 2025, after the market closes. This presentation is highly...

Continue Reading